BIZARRE: 2 - What They Never Told You

Stocks Fall Back on Disappointing Earnings from Cisco and Walmart

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.31%. Stocks this morning are mildly lower on some disappointing...

Barchart · Nov 16, 2023

PayPal Q3 Is ‘All About’ New CEO’s Vision: 5 Analysts Explore Earnings, Prospects

Shares of PayPal Holdings Inc (NASDAQ: PYPL) rose in early trading on Thursday, after the company reported its third-quarter (Q3) results

Zenger · Nov 3, 2023

Block’s Stock Crashes Even After Beat-And-Raise Quarter, 5 Analysts Deep Dive Into Print

Shares of Block Inc (NYSE: SQ) tanked in early trading on Friday, even after the company’s beat and raise quarter

Zenger · Aug 5, 2023

EBay "Thesis Not Changing" Analysts Say After Strong Guidance, Mixed Earnings

Analysts are sizing up the second-quarter financial report from marketplace and auction company eBay Inc (NASDAQ: EBAY), which reported results Wednesday after market close. The eBay Analysts: Needham analyst Anna Andreeva had a Hold rating and no price target.

Benzinga · Aug 4, 2022

Mizuho Cuts WEC Energy's Price Target By 13%

Mizuho Securities analyst Anthony Crowdell lowered the price target on WEC Energy Group Inc (NYSE:WEC) to $93 (an upside of 3%) from $107 while maintaining the Neutral rating on the shares. Mizuho hosted investor meetings with WEC’s Executive Chairman Gale Klappa and CFO Xia Liu. Crowdell says that the management highlighted the strong 6-7% EPS…

Benzinga · Jun 17, 2022

Read How Analysts Reacted To Devon Energy's RimRock Transaction

Mizuho Securities analyst Vincent Lovaglio raised the price target for Devon Energy Corp (NYSE:DVN) to $94 (an upside of 28%) from $92, reflecting the $865 million Rim Rock acquisition. The analyst states that the transaction adds 15kboed and 38k net acres to the company's existing 48kboed and 85k net acre Bakken position at ~4x free cash…

Benzinga · Jun 10, 2022

Mizuho Remains Bullish On This Small-Cap Stock's Migraine Candidate, But Why Did It Cut Price Target

Mizuho Securities says that the Satsuma Pharmaceuticals Inc (NASDAQ: STSA) story is essentially unchanged. It remains bullish on STS101's potential as an effective, safe, and reliable intranasal dihydroergotamine (DHE) for migraine. 

Benzinga · May 13, 2022

Rivian Is A 'Show-Me-The-Money' Story But Has 'More Pieces In Place' Than Peers: Analysts React To Q1 Earnings

Electric vehicle company Rivian Automotive Inc (NASDAQ: RIVN) reported first-quarter production of 2,553 vehicles. The company delivered 1,227 vehicles in the first quarter and reported more than 90,000 net pre-orders of its Rivian R1 electric pickup truck.

Benzinga · May 12, 2022

Analysts Say Acadia's Negative Pain Data Increases Focus On Pimavanserin For Alzheimer's-Related Psychosis

Acadia Pharmaceuticals Inc (NASDAQ:ACAD) announced the primary endpoint miss of the phase 2 POC study of ACP-044 in acute postoperative pain following bunionectomy, a surgical procedure that moves toes back into the correct position.  RBC Capital Markets writes that although trends of pain reduction were observed in the 400 mg QID ACP-044 arm compared…

Benzinga · Apr 19, 2022

Why This Analyst Believes Okta Stock Is 'Difficult To Ignore,' Noting An Increase In Cybersecurity Needs

Shares of Okta Inc (NASDAQ: OKTA) have lost 42% over the past six months, while the company’s organic growth remains strong, according to Mizuho Securities.

Benzinga · Mar 8, 2022